You are here: Industry Insights > Neurodegeneration

News List

AbbVie and Calico extend partnership on drugs for age-related diseases pharmaceutical-technology
July 29, 2021
AbbVie and Calico Life Sciences have expanded their partnership to discover, develop and commercialise novel treatments for age-related diseases such as neurodegeneration and cancer.
New research identifies single biomarker that can indicate underlying neurodegeneration pharmatimes
June 09, 2021
New research has identified a single biomarker that can be used to accurately identify underlying neurodegeneration among people with cognitive issues.
XPro1595 significantly improves neurodegeneration in AD trial europeanpharmaceuticalreview
January 26, 2021
Treatment with XPro1595 for three months caused significant changes in neurodegeneration, synaptic function and neuroinflammation.
Sosei doses first patient with experimental neurodegenerative drug pharmatimes
December 14, 2018
Sosei has announced that the first healthy subject has been dosed with HTL0014242 - a novel small molecule being tested for its ability to slow neurodegeneration.
Roche-backed Minoryx raises €21M to expand CNS R&D fiercebiotech
September 27, 2018
Minoryx has raised €21.3 million in series B funding. The round sets Minoryx up to expand clinical development of a neurodegenerative disease drug that has attracted the interest of organizations including Roche Venture Fund.
Sugar can delay neurodegeneration caused by enzyme deficiency pharmaceutical-technology
June 28, 2018
A team of researchers from Baylor College of Medicine in the US have found that a new therapeutic approach of using simple sugar can help in delaying neurodegeneration associated with disease mucopolysaccharidoses IIIB (MPS IIIB).
New target could yield treatment for Alzheimer's, ALS and more fiercebiotech
August 17, 2017
Researchers led by Genentech have discovered a new drug target for neurodegenerative diseases.